Filed (PHiled). Greater than 1-2 years since publication

Infradiaphragmatic anomalous pulmonary venous return. Surgical correction in a newborn infant

Beat Friedli, Andre Davignon, Paul StanleyUniversity of Montreal and Sainte Justine HospitalCanada Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 1971; 62: 301-306DOI: Not Available AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and Catheter-mediated Interventions for Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed […]

Infradiaphragmatic anomalous pulmonary venous return. Surgical correction in a newborn infant Read More »

Concepts and practices in surgery for total anomalous pulmonary venous connection

Nevin M. Katz, John W. Kirklin, Albert D. PacificoUniversity of Alabama School of Medicine and Medical Center.United States Annals of Thoracic SurgeryAnn Thorac Surg 1978; 25: 479-487DOI: 10.1016/s0003-4975(10)63593-x AbstractIn the last ten years there have been extensive refinements in the surgical approach to total anomalous pulmonary venous connection (TAPVC). This communication reviews determinants of hosptal mortality

Concepts and practices in surgery for total anomalous pulmonary venous connection Read More »

Individual pulmonary vein size and survival in infants with totally anomalous pulmonary venous connection

Kathy J. Jenkins, Stephen P. Sanders, E. John Orav, Elizabeth A. Coleman, John E. Mayer Jr., Steven D. ColanChildren’s Hospital, Boston.United States Journal of the American College of CardiologyJ Am Coll Cardiol 1993; 22(1):201-206DOI: 10.1016/0735-1097(93)90835-o AbstractObjectives: We investigated whether mortality in totally anomalous pulmonary venous connection could be predicted from preoperative individual pulmonary vein size.Background: Some infants with

Individual pulmonary vein size and survival in infants with totally anomalous pulmonary venous connection Read More »

Cardiac medical conditions have become the leading cause of death in children with heart disease

Tobias R. Schlingmann, Ravi R. Thiagarajan, Kimberlee Gauvreau, Kimberly C. Lofgren, Michael Zaplin, Jean A. Connor, Pedro J. del Nido, James E. Lock, Kathy J. JenkinsChildren’s Hospital Boston and Harvard Medical School.United States Congenital Heart DiseaseCongenit Heart Dis 2012; 7: 551-558DOI: 10.1111/j.1747-0803.2012.00674.x AbstractObjective: Mortality among children with congenital and acquired heart disease has decreased significantly over the

Cardiac medical conditions have become the leading cause of death in children with heart disease Read More »

The Role of Elevated Wall Shear Stress in Progression of Pulmonary Vein Stenosis: Evidence from Two Case Studies

Peter E. Hammer, Kerry McEnaney, Ryan Callahan, Christopher W. Baird, David M. Hoganson, Kathy J. JenkinsBoston Children’s Hospital.United States ChildrenChildren 2021; 8:DOI: 10.3390/children8090729 AbstractPulmonary vein stenosis is a serious condition characterized by restriction or blockage due to fibrotic tissue ingrowth that develops in the pulmonary veins of infants or children. It is often progressive and can

The Role of Elevated Wall Shear Stress in Progression of Pulmonary Vein Stenosis: Evidence from Two Case Studies Read More »

Continuous Positive Airway Pressure in the Treatment of Pediatric High Altitude Pulmonary Edema: A Case Study

Ryan Hodnick, Michael L. Cohen, Joseph B. Loehner, Jennifer MazzantiTrans Aero Medevac. TriState CareFlight.United States Wilderness and Environmental MedicineWilderness Environ Med 2024; DOI: 10.1177/10806032231222003 AbstractTreatment of high altitude pulmonary edema (HAPE) can be challenging and is further complicated in the pediatric patient in the prehospital environment. The following case presents a decompensating pediatric patient with HAPE in the prehospital

Continuous Positive Airway Pressure in the Treatment of Pediatric High Altitude Pulmonary Edema: A Case Study Read More »

Elevated transaminases in congenital central hypoventilation syndrome

Rachel Y. Wang, Victoria S. Wang, Thomas G. Keens, Yan Chai, Nisreen Soufi, Iris A. PerezChildren’s Hospital Los Angeles.United States European Respiratory Journal Open ResearchERJ Open Res 2024; 10:DOI: 10.1183/23120541.00658-2023 AbstractPatients with CCHS who also have Hirschsprung disease, elevated or low BMI, or pulmonary hypertension may be predisposed to elevated transaminases and may need periodic follow-up

Elevated transaminases in congenital central hypoventilation syndrome Read More »

Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey

Martin Hosking, Angela BatesUniversity of British Columbia. University of Alberta.Canada Canadian Journal of CardiologyCan J Cardiol 2024;DOI: 10.1016/j.cjca.2024.02.009 AbstractAbstract Not Available CategoryMedical Therapy. Efficacy or Lack of Efficacy Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article AccessFree PDF File or Full Text Article Available Through

Therapy in pediatric pulmonary hypertension: memoire of an unfinished journey Read More »

Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry

Julie Wacker, Tilman Humpl, Rolf M. F. Berger, Dunbar Ivy, David Bowers, Damien Bonnet, Maurice Beghetti on behalf of the TOPP InvestigatorsChildren’s University Hospital and University of Geneva. Hospital for Sick Children and University of Toronto. Beatrix Children’s Hospital, University Medical Center Groningen and University of Groningen. Children’s Hospital Colorado and University of Colorado School

Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry Read More »

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study

Dunbar Ivy, Maurice Beghetti, Ernesto Juaneda‑Simian, Ramiya Ravindranath, Mary Ann Lukas, Sandra Machlitt‑Northen, Nicola Scott, Jun Narita, Rolf M. F. BergerChildren’s Hospital Colorado. University Children’s Hospital HUG and University of Geneva. Hospital de Niños de la Santísma Trinidad. Glaxo-Smith-Kline. Osaka University Graduate School of Medicine. Beatrix Children’s Hospital, University Medical Center Groningen and University of

Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study Read More »

Scroll to Top